8 known cases. View patent page →
One of the consolidated D.N.J. Xyrem ANDA actions against Ranbaxy. A consolidation stipulation recites that this action alleged infringement of a patent list including US 6,780,889; it was consolidated with related Xyrem actions and resolved/terminated in the 2015-2018 window.
D.N.J. Xyrem ANDA action against Watson, consolidated with the Ranbaxy and Amneal Xyrem actions for a 500 mg/ml generic sodium oxybate oral solution. The narrative identifies it among the Hatch-Waxman suits filed by Jazz on US 6,780,889; it was resolved/terminated in the 2015-2018 window.
MDL antitrust litigation in N.D. Cal. in which US 6,780,889 is listed among the patents at issue, along with US 10,213,400, US 10,864,181, and US 7,262,219, among others. The claims are antitrust, not patent infringement.
Antitrust action in N.D. Cal. against Jazz Pharmaceuticals; the complaint names US 6,780,889 among the patents at issue. The narrative describes it as a payor/indirect-purchaser Xyrem antitrust action.
Antitrust/payor action in N.D. Ill. against Jazz Pharmaceuticals; US 6,780,889 is named among the patents at issue. Terminated on 2020-07-14, consistent with the July 2020 voluntary dismissals of payor suits to pursue claims in the N.D. Cal. MDL.
Antitrust/payor action in N.D. Ill. against Jazz Pharmaceuticals; US 6,780,889 is named among the patents at issue. Terminated on 2020-07-15.
D. Del. generic-vs-generic action listed on DrugPatentWatch's US 6,780,889 litigation page. The narrative flags this as a low-confidence attribution, possibly a database cross-listing artifact, and could not corroborate that US 6,780,889 was actually asserted.
Jazz Pharmaceuticals sued Ranbaxy Laboratories and Ranbaxy Inc. in a Hatch-Waxman ANDA patent infringement action over generic sodium oxybate referencing Xyrem. The complaint asserted multiple patents including U.S. Patent No. 8,461,203. The case was consolidated for all purposes into Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC, No. 13-391-ES-JAD, and administratively terminated.